Ned Milenkovich, co-chair of Much’s Health Care group, spoke with Gizmodo about the increasing prominence of peptides in the health care space. After authoring a recent article for Pharmacy Times, Milenkovich continued the discussion about how peptides are gaining attention in the industry, though they vary widely in regulatory oversight.
Milenkovich stressed that decisions about peptide use should be made with a licensed health care provider and sourced through regulated medical channels, as the science and regulatory frameworks are still catching up to the market’s rapid growth.